EXPLOITS DISCOVERY CORP. IDENTIFIES NEW GOLD ANOMALIES USING SGH SOIL SURVEY AT THE JP VEIN JONATHAN’S POND AND SHIPS AN ADDITIONAL 3,062 SOIL SAMPLES FOR SGH ANALYSIS

EXPLOITS DISCOVERY CORP. IDENTIFIES NEW GOLD ANOMALIES USING SGH SOIL SURVEY AT THE JP VEIN JONATHAN’S POND AND SHIPS AN ADDITIONAL 3,062 SOIL SAMPLES FOR SGH ANALYSIS

November 24th , 2020 – Exploits Discovery Corp., (“Exploits” or the “Company”) (CSE:NFLD) (CNSX:NFLD.CN) (OTC:RNRRF) (FSE:634-FF) is pleased to announce that it has received the results from the orientation Spatiotemporal Geochemical Hydrocarbon (SGH) soil program over known mineralization at Jonathan’s Pond and completed the collection of SGH samples at the Dog Bay and True Grit […]

K9 Gold 2020 Exploration Program Update for Stony Lake, Adds Technical Adviser

K9 Gold 2020 Exploration Program Update for Stony Lake, Adds Technical Adviser

Vancouver, British Columbia–(Newsfile Corp. – November 25, 2020) –  K9 Gold Corp. (TSXV: KNC) (FSE: 5GP) (“K9” or the “Company”) is pleased to announce the addition of Dr. Andreas Rompel to its technical advisory board. Dr. Rompel is a seasoned exploration professional with nearly three decades of exploration experience in a wide range of roles from VP […]

Marathon Gold arranges $8.65-million private placement

Marathon Gold arranges .65-million private placement

Marathon Gold Corp. has arranged a strategic flow-through financing to continue the company’s successful exploration program at the Valentine gold project in central Newfoundland. The non-brokered private placement offering consists of 3,037,418 flow-through common shares priced at $2.85 per flow-through common share for total proceeds of $8,656,641. As part of the offering, Marathon is pleased […]

MindMed Upsizes Previously Announced Bought Deal Public Offering

MindMed Upsizes Previously Announced Bought Deal Public Offering

NEW YORK, Nov. 25, 2020 /CNW/ – Mind Medicine (MindMed) Inc. (NEO: MMED) (OTCQB: MMEDF) (“MindMed” or the “Company”), the leading neuro-pharmaceutical company for psychedelic inspired medicines, is pleased to announce that it has agreed to increase the size of its previously announced bought deal financing led by Canaccord Genuity Corp. (the “Lead Underwriter”). The Lead Underwriter […]

MindMed Announces $25 Million Bought Deal Public Offering

MindMed Announces  Million Bought Deal Public Offering

NEW YORK, Nov. 25, 2020 /CNW/ – Mind Medicine (MindMed) Inc. (NEO: MMED) (OTCQB: MMEDF) (“MindMed” or the “Company”), the leading neuro-pharmaceutical company for psychedelic inspired medicines, is pleased to announce that it has entered into an agreement with Canaccord Genuity Corp. (the “Lead Underwriter”) pursuant to which the Lead Underwriter has agreed, on behalf of a […]